We are live on
!
Find out more
DBTX
Decibel Therapeutics, Inc. Common Stock
DBTX
DBTX
Delisted
DBTX was delisted on the 22nd of September, 2023.
46 hedge funds and large institutions have $168M invested in Decibel Therapeutics, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 7 increasing their positions, 17 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
15% less funds holding
Funds holding: 54 → 46 (-8)
26% less capital invested
Capital invested by funds: $226M → $168M (-$58.2M)
42% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 19
59% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 17
Holders
46
Holders Change
-8
Holders Change %
-14.81%
% of All Funds
0.8%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
7
Reduced
17
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$2.24M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.66M |
| 3 |
BCM
Bronte Capital Management
Bondi Junction,
Australia
|
+$1.41M |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$635K |
| 5 |
Morgan Stanley
New York
|
+$600K |
Top Sellers
| 1 |
BlackRock
New York
|
-$2.93M |
| 2 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$2.27M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.93M |
| 4 |
State Street
Boston,
Massachusetts
|
-$661K |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$652K |
